133 related articles for article (PubMed ID: 37666247)
1. Multimodal fluorescence imaging and spectroscopic techniques for oral cancer screening: a real-time approach.
Thapa P; Singh V; Bhatt S; Maurya K; Kumar V; Nayyar V; Jot K; Mishra D; Shrivastava A; Mehta DS
Methods Appl Fluoresc; 2023 Sep; 11(4):. PubMed ID: 37666247
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic characterization of oral epithelial dysplasia and squamous cell carcinoma using multiphoton autofluorescence micro-spectroscopy.
Pal R; Edward K; Ma L; Qiu S; Vargas G
Lasers Surg Med; 2017 Nov; 49(9):866-873. PubMed ID: 28677822
[TBL] [Abstract][Full Text] [Related]
3. In vivo autofluorescence spectroscopy of oral premalignant and malignant lesions: distortion of fluorescence intensity by submucous fibrosis.
Tsai T; Chen HM; Wang CY; Tsai JC; Chen CT; Chiang CP
Lasers Surg Med; 2003; 33(1):40-7. PubMed ID: 12866120
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence visualization improves the detection of oral, potentially malignant, disorders in population screening.
Simonato LE; Tomo S; Scarparo Navarro R; Balbin Villaverde AGJ
Photodiagnosis Photodyn Ther; 2019 Sep; 27():74-78. PubMed ID: 31116999
[TBL] [Abstract][Full Text] [Related]
5. History and future perspectives for the use of fluorescence visualization to detect oral squamous cell carcinoma and oral potentially malignant disorders.
Tomo S; Miyahara GI; Simonato LE
Photodiagnosis Photodyn Ther; 2019 Dec; 28():308-317. PubMed ID: 31600576
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive imaging of oral potentially malignant and malignant lesions: A systematic review and meta-analysis.
Mendonca P; Sunny SP; Mohan U; Birur N P; Suresh A; Kuriakose MA
Oral Oncol; 2022 Jul; 130():105877. PubMed ID: 35617750
[TBL] [Abstract][Full Text] [Related]
7. Autofluorescence imaging in recurrent oral squamous cell carcinoma.
Scheer M; Fuss J; Derman MA; Kreppel M; Neugebauer J; Rothamel D; Drebber U; Zoeller JE
Oral Maxillofac Surg; 2016 Mar; 20(1):27-33. PubMed ID: 26267490
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of light based detection systems for early detection of oral cancer and oral potentially malignant disorders: Systematic review.
Nagi R; Reddy-Kantharaj YB; Rakesh N; Janardhan-Reddy S; Sahu S
Med Oral Patol Oral Cir Bucal; 2016 Jul; 21(4):e447-55. PubMed ID: 26946209
[TBL] [Abstract][Full Text] [Related]
9. Optical fluorescence imaging in oral cancer and potentially malignant disorders: A systematic review.
Tiwari L; Kujan O; Farah CS
Oral Dis; 2020 Apr; 26(3):491-510. PubMed ID: 30810255
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of autofluorescence in diagnosing oral squamous cell carcinoma and oral potentially malignant disorders: a comparative study with aero-digestive lesions.
Luo X; Xu H; He M; Han Q; Wang H; Sun C; Li J; Jiang L; Zhou Y; Dan H; Feng X; Zeng X; Chen Q
Sci Rep; 2016 Jul; 6():29943. PubMed ID: 27416981
[TBL] [Abstract][Full Text] [Related]
11. Healthcare Professional in the Loop (HPIL): Classification of Standard and Oral Cancer-Causing Anomalous Regions of Oral Cavity Using Textural Analysis Technique in Autofluorescence Imaging.
Awais M; Ghayvat H; Krishnan Pandarathodiyil A; Nabillah Ghani WM; Ramanathan A; Pandya S; Walter N; Saad MN; Zain RB; Faye I
Sensors (Basel); 2020 Oct; 20(20):. PubMed ID: 33053886
[TBL] [Abstract][Full Text] [Related]
12. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
13. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
14. CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma.
Silva LC; Fonseca FP; Almeida OP; Mariz BA; Lopes MA; Radhakrishnan R; Sharma M; Kowalski LP; Vargas PA
Med Oral Patol Oral Cir Bucal; 2020 Jan; 25(1):e49-e55. PubMed ID: 31880289
[TBL] [Abstract][Full Text] [Related]
15. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
[TBL] [Abstract][Full Text] [Related]
16. Molecular diagnostics in oral cancer and oral potentially malignant disorders-A clinician's guide.
Yap T; Celentano A; Seers C; McCullough MJ; Farah CS
J Oral Pathol Med; 2020 Jan; 49(1):1-8. PubMed ID: 31309636
[TBL] [Abstract][Full Text] [Related]
17. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
18. A Real-Time Near-Infrared Fluorescence Imaging Method for the Detection of Oral Cancers in Mice Using an Indocyanine Green-Labeled Podoplanin Antibody.
Ito A; Ohta M; Kato Y; Inada S; Kato T; Nakata S; Yatabe Y; Goto M; Kaneda N; Kurita K; Nakanishi H; Yoshida K
Technol Cancer Res Treat; 2018 Jan; 17():1533033818767936. PubMed ID: 29649929
[TBL] [Abstract][Full Text] [Related]
19. In-vivo Testing of Oral Mucosal Lesions with an In-house Developed Portable Imaging Device and Comparison with Spectroscopy Results.
Sah AN; Kumar P; Pradhan A
J Fluoresc; 2023 Jul; 33(4):1375-1383. PubMed ID: 36701084
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders.
Yap T; Seers C; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; McCullough M
Oral Oncol; 2019 Sep; 96():113-120. PubMed ID: 31422202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
